Tag: Cml

According to official prescribing information and clinical reports, night sweats are a common side effect of the cancer medication imatinib. While often mild, they can be bothersome and interfere with a patient's sleep and quality of life.

Originally approved in the early 2000s, imatinib—often known by brand names like Imanib and Gleevec—revolutionized the treatment landscape for certain cancers. A common question for many patients and caregivers is, **What is Imanib 400 mg used for?** It is a targeted therapy designed to block specific proteins that cause cancer cells to grow and multiply.

Synribo (omacetaxine mepesuccinate) was permanently discontinued due to manufacturing issues, with remaining inventory expected to be exhausted in late 2023. This article explores the detailed reasons for its withdrawal and its place in cancer therapy.

Bosulif (bosutinib) is a targeted cancer medicine primarily used to treat Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults and children aged 1 year and older. It is prescribed for newly diagnosed patients, as well as for those who are resistant or intolerant to other treatments.